Skip to main content

Table 1 Baseline characteristics of the study population

From: Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study

  OVERT ARVD/C
(N = 39)
Preclinical ARVD/C (n = 40) Controls
(n = 31)
Female (%) 22 (56) 18 (45) 14 (45)
Age (yrs) 32.3 ± 13.5 31.3 ± 18.1 37.2 ± 14.9
Global CMR parameters  
RV EDV/BSA (mL/m2) 88.3 ± 25.6a 68.4 ± 14.4 69.7 ± 12.9
RV ESV/BSA (mL/m2) 47.4 ± 24.9a 31.1 ± 9.8 30.0 ± 8.6
RV EF (%) 48.3 ± 11.7a 54.9 ± 9.6 56.9 ± 9.7
LV EDV/BSA (mL/m2) 77.4 ± 12.1 69.1 ± 12.9 73.5 ± 9.6
LV ESV/BSA (mL/m2) 30.6 ± 9.5 25.2 ± 7.0 30.9 ± 15.1
LV EF (%) 62.7 ± 6.3 63.2 ± 11.7 58.9 ± 13.3
Clinical Phenotype
Repolarization criteria    -
 Major 36 (93) 1 (3)  
 Minor 22 (54) 19 (48)  
Depolarization criteria    -
 Major 3 (8) 0 (0)  
 Minor 19 (49) 18 (45)  
Arrhythmia criteria    -
 Major 7 (18) 0 (0)  
 Minor 26 (67) 4 (10)  
Structural criteria    -
 Major 16 (41) 0 (0)  
 Minor 7 (18) 0 (0)  
TFC fulfillment: number of criteria (median) 6 (IQR 5–7) 2 (IQR 2–3) -
  1. Abbreviations: ARVD/C Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy, BSA Body Surface Area, EDV End-Diastolic Volume, EF Ejection Fraction, ESV End-Systolic Volume, TFC Task Force Criteria, N number of subjects
  2. a Statistical significant difference compared to control subjects